ASSIST: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/1ce6c48d2111d610379202bcd9bcfd1a.pdf

Abstract Title

First Name *

Irene L.

Last Name *

Noronha

Co-author 1

Jonathan Barratt jb81@leicester.ac.uk University Hospitals of Leicester NHS Trust Department of Cardiovascular Sciences, Renal Medicine Leicester

Co-author 2

Jose Luis Górriz j.luis.gorriz@uv.es Hospital Clínico Universitario de Valencia Nephrology Department Valencia

Co-author 3

Sradha Kotwal skotwal@georgeinstitute.org.au Prince of Wales Hospital The George Institute for Global Health Sydney

Co-author 4

Soo Kun Lim limsk@ummc.edu.my University Malaya Medical Centre Department of Medicine Kuala Lumpur

Co-author 5

Valeria Beckett vbeckett@chinooktx.com Chinook Therapeutics, A Novartis Company Biostatistics Seattle

Co-author 6

Marianne Camargo mcamargo@chinooktx.com Chinook Therapeutics, A Novartis Company Clinical Development Seattle

Co-author 7

Amy K. Mottl amy_mottl@med.unc.edu University of North Carolina at Chapel Hill Division of Nephrology and Hypertension Chapel Hill

Co-author 8

Hiddo J L Heerspink h.j.lambers.heerspink@umcg.nl University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology Groningen

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15